throbber
Trials@uspto.gov
`Tel: 571-272-7822
`
`
`
`
`
`Paper 5
`Date: June 18, 2020
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`TEVA PHARMACEUTICALS USA, INC. AND WATSON
`LABORATORIES, INC.
`Petitioner,
`
`v.
`
`MERCK SHARP & DOHME CORP.,
`Patent Owner.
`_____________
`
`IPR2020-01045 (Patent 7,326,708 B2)
`_______________
`
`Before SHERIDAN K. SNEDDEN, ROBERT A. POLLLOCK, and
`TIMOTHY G. MAJORS, Administrative Patent Judges.
`
`MAJORS, Administrative Patent Judge.
`
`
`
`
`ORDER
`Conduct of the Proceeding
`37 C.F.R. § 42.5
`
`
`
`
`
`
`
`
`
`

`

`IPR2020-01045 (Patent 7,326,708 B2)
`
`On June 17, 2020, the parties conferred with the Board on Petitioner
`Teva’s motion for joinder. Paper 4. The conference was attended by the
`panel and counsel for Teva, Merck (Patent Owner), and Mylan (Petitioner in
`IPR2020-00040). During the call, Patent Owner’s counsel indicated that it
`was reserving its rights as to whether it intended to oppose Petitioner Teva’s
`motion, and stated that Patent Owner was seeking further information from
`Mylan and Teva regarding the scope of Teva’s participation if it was joined
`in IPR2020-00040.
`The parties’ counsel further informed the panel that at least two
`additional petitions and motions for joinder were recently filed by additional
`challengers to the patent that is the subject of instituted proceedings
`IPR2020-00040 and the petition in IPR2020-01045. Petitioners in those
`other matters have not yet conferred with the Board concerning such other
`petitions and motions for joinder.
`To help narrow potentially disputed issues related to Teva’s motion
`for joinder, the Board encouraged counsel for Mylan and Teva to confer
`(and, if possible, to also confer with the Petitioners in the other two recently-
`filed cases). Petitioners’ counsel should then confer with counsel for Merck
`to determine whether issues related to the motion(s) for joinder remain in
`dispute.
`The Board asked that Teva’s counsel update the Board via email by
`June 23, 2020, on whether such discussions between the parties have taken
`place.
`Absent further order of the Board, the deadlines for any opposition or
`reply to Teva’s motion for joinder are the default filing times according to
`our rules. 37 C.F.R. § 42.25. We will, however, consider a request modify
`the briefing schedule as appropriate. Petitioner Mylan is not permitted to
`
`2
`
`

`

`IPR2020-01045 (Patent 7,326,708 B2)
`
`file any responsive paper in IPR2020-00040 on Teva’s motion absent prior
`Board authorization.
`SO ORDERED.
`
`
`
`
`
`
`
`
`3
`
`

`

`IPR2020-01045 (Patent 7,326,708 B2)
`
`FOR PETITIONER:
`Keith A. Zullow
`Sarah J. Fischer
`Goodwin Procter LLP
`kzullow@goodwinprocter.com
`sfischer@goodwinprocter.com
`
`
`FOR PATENT OWNER:
`Philippe Durette
`Merck & Co., Inc.
`P.O. Box 2000
`Rahway, NJ 07065-0907
`
`4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket